Literature DB >> 11903823

Co-existence between oral lesions and opportunistic systemic diseases among HIV-infected subjects in Thailand.

Wipawee Nittayananta1, Nilnara Chanowanna, Than Winn, Khachornsakdi Silpapojakul, Amorn Rodklai, Sutep Jaruratanasirikul, Kriengsak Liewchanpatana.   

Abstract

BACKGROUND: The purpose of this study was to determine whether any relationship exists between the occurrence of oral lesions and opportunistic systemic diseases among HIV-infected subjects.
METHODS: A cross-sectional analytical study was performed in two hundred and seventy-eight HIV-infected heterosexual persons and intravenous drug users (IVDUs)(230 males and 48 females, aged 16-65 years, mean 31.9 years). Eighty-six HIV-free subjects from the same population were included as controls (61 males and 25 females, aged 17-63 years, mean age 33.1 years). The following information was recorded for each patient: age, gender, risk group and stage of HIV infection, immune status, medication, systemic disease and presence of oral lesions.
RESULTS: Oral candidiasis was the most common oral lesion among HIV-infected individuals (40%), followed by hairy leukoplakia (HL)(26%). The three most common systemic diseases among the subjects were tuberculosis (TB)(53%), cryptococcosis (14%) and Pneumocystis carinii pneumonia (PCP)(11%). Logistic regression analysis revealed a significant association between the occurrence of TB and the presence of oral candidiasis (OR 2.8; 95% CI 1.6-4.8; P < 0.001), and the occurrence of PCP and the presence of HL (OR 2.2; 95% CI 1.1-4.3; P < 0.001). Positive predictive values of any oral lesions and oral candidiasis in predicting TB were 87% (95% CI 73.0-94.6) and 67% (95% CI 51.9-80.0), respectively.
CONCLUSIONS: We concluded that oral candidiasis might be used as a clinical marker for TB, and HL for PCP. Recognition of the lesions by health-care providers may indicate the need for more intensive clinical and laboratory monitoring and possibly initiation of prophylaxis against these opportunistic systemic infections.

Entities:  

Mesh:

Year:  2002        PMID: 11903823     DOI: 10.1034/j.1600-0714.2002.310307.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.

Authors:  Bisola O Ojikutu; Hui Zheng; Rochelle P Walensky; Zhigang Lu; Elena Losina; Janet Giddy; Kenneth A Freedberg
Journal:  S Afr Med J       Date:  2008-03

2.  Oral manifestations of HIV in children receiving anti-retroviral therapy in Hyderabad, India.

Authors:  P V Baghirath; A B Krishna; A Gannepalli; M M Ali
Journal:  Eur Arch Paediatr Dent       Date:  2013-06-13

3.  Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania.

Authors:  Omar J M Hamza; Mecky I N Matee; Elison N M Simon; Emil Kikwilu; Mainen J Moshi; Ferdinand Mugusi; Frans H M Mikx; Paul E Verweij; André J A M van der Ven
Journal:  BMC Oral Health       Date:  2006-08-18       Impact factor: 2.757

4.  Gender differences in oral manifestations among HIV-infected Brazilian adults.

Authors:  Maria Dongo; Lucio Souza Gonçalves; Sônia Maria S Ferreira; Cesar Werneck Noce; Eliane Pedra Dias; Arley Silva Júnior
Journal:  Int Dent J       Date:  2013-05-14       Impact factor: 2.607

5.  Oral Manifestations in HIV-TB Co- infected Patients and Their Correlation with CD4 Count in Telangana State, India.

Authors:  Ashalata Gannepalli; Ayinampudi B Krishna; Pacha V Baghirath; Balistty Hari Vinay; Sana Khaled; Bushra Anjum
Journal:  J Int Soc Prev Community Dent       Date:  2020-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.